RESUMO
Scorpion stings occur on every continent except Antarctica. The correlation between young age and severity of clinical manifestations after this envenomation is well-established. Several studies have emphasized the relevance of pro-inflammatory mediators in the pathophysiological manifestations of human scorpion envenomation. Moreover, there is a significant association between pro-inflammatory cytokine levels in the blood and the severity of scorpion envenomation. Release of these cytokines increases the severity of the visceral damage induced by the direct action of the venom and the activation of both the sympathetic and parasympathetic nervous systems.
Assuntos
Insuficiência de Múltiplos Órgãos/fisiopatologia , Picadas de Escorpião/fisiopatologia , Animais , Catecolaminas/metabolismo , Citocinas/metabolismo , Humanos , Inflamação/imunologia , Inflamação/fisiopatologia , Insuficiência de Múltiplos Órgãos/imunologia , Picadas de Escorpião/imunologiaAssuntos
Infecções por Acinetobacter/tratamento farmacológico , Acinetobacter baumannii/isolamento & purificação , Antibacterianos/uso terapêutico , Colistina/uso terapêutico , Infecção Hospitalar/tratamento farmacológico , Meningites Bacterianas/tratamento farmacológico , Complicações Pós-Operatórias/tratamento farmacológico , Tigeciclina/uso terapêutico , Infecções por Acinetobacter/etiologia , Infecções por Acinetobacter/microbiologia , Acinetobacter baumannii/efeitos dos fármacos , Adolescente , Antibacterianos/administração & dosagem , Lesões Encefálicas Traumáticas/complicações , Lesões Encefálicas Traumáticas/cirurgia , Derivações do Líquido Cefalorraquidiano/efeitos adversos , Colistina/administração & dosagem , Coma/etiologia , Craniotomia/efeitos adversos , Infecção Hospitalar/etiologia , Infecção Hospitalar/microbiologia , Farmacorresistência Bacteriana Múltipla , Humanos , Masculino , Meningites Bacterianas/etiologia , Meningites Bacterianas/microbiologia , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/microbiologia , Tigeciclina/administração & dosagemRESUMO
Venous thromboembolism (VTE) remains a major challenge in critically ill patients. Subjects admitted in intensive care unit (ICU), in particular trauma patients, are at high-risk for both deep vein thrombosis (DVT) and pulmonary embolism (PE). The rate of symptomatic PE in injured patients has been reported previously ranging from 1 to 6%. The high incidence of posttraumatic venous thromboembolic events is well known. In fact, major trauma is a hypercoagulable state. Several factors placing the individual patient at a higher risk for the development of DVT and PE have been suggested: high ISS score, meningeal hemorrhage and spinal cord injuries have frequently been reported as a significant risk factor for VTEs after trauma. Posttraumatic pulmonary embolism traditionally occurs after a period of at least 5 days from trauma. The prevention can reduce the incidence and mortality associated with the pulmonary embolism if it is effective. There is no consensus is now available about the prevention of venous thromboembolism in trauma patients.